ADAMTS19
Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene has high sequence similarity to the protein encoded by ADAMTS16, another family member. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
ADAM metallopeptidase with thrombospondin type 1 motif 19 | MIM:607513 | Ensembl:ENSG00000145808 | HGNC:HGNC:17111 | PA24545 | 5q23.3 |
GO terms in ADAMTS19
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0004222 | metalloendopeptidase activity |
MF | IEA | GO:0046872 | metal ion binding |
BP | IEA | GO:0006508 | proteolysis |
CC | IEA | GO:0005576 | extracellular region |
Gene expression in normal tissue: ADAMTS19
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ADAMTS19
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1643685 | Disease |
reactome | R-HSA-3781865 | Diseases of glycosylation |
reactome | R-HSA-3906995 | Diseases associated with O-glycosylation of proteins |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-5083635 | Defective B3GALTL causes Peters-plus syndrome (PpS) |
reactome | R-HSA-5173105 | O-linked glycosylation |
reactome | R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins |
reactome | R-HSA-597592 | Post-translational protein modification |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD505 | Pevonedistat | 3 |
iGMDRD147 | Prima-1 | 1 |
iGMDRD322 | FK 866 | 3 |
iGMDRD286 | Nsc 632839 | 8 |
iGMDRD329 | Merck60 | 3 |
iGMDRD267 | Oligomycin A | 3 |
iGMDRD103 | SN-38 | 3 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD202 | Curcumin | 3 |
iGMDRD158 | NSC141540 | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD177 | Teniposide | 3 |
iGMDRD341 | Triacsin c | 3 |
iGMDRD116 | CD437 | 3 |
iGMDRD560 | MK-2206 | 1 |
iGMDRD150 | RITA | 3 |
iGMDRD512 | nutlin 3 | 1 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD506 | Fedratinib | 7 |
iGMDRD398 | Sepantronium | 2 |
iGMDRD780 | PP-30 | 2 |
iGMDRD52 | Rotenone | 3 |
iGMDRD870 | BRD63610 | 3 |
iGMDRD679 | Bistramide A | 4 |
iGMDRD634 | SCHEMBL2608041 | 3 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
iGMDRD61 | Kinetin riboside | 2 |
iGMDRD670 | ML 210 | 3 |
iGMDRD144 | NSC95397 | 5 |
iGMDRD494 | Neopeltolide | 3 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD420 | Leucascandrolide A | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ADAMTS19